PINK:SKYE

Skye Bioscience Stock Forecast

etoro logo Buy SKYE
*Your capital is at risk
$0.662
-0.0280 (-4.06%)
At Close: Jul 13, 2026
AI Analysis AI Analysis of SKYE AI-Powered Market Insights
Stock Analysis PRO New!
Risk Assessment PRO New!
Trading Strategy PRO New!
Add SKYE to Watchlist?
  • Easy Tracking In The Watchlist
PDF

Red day on Monday for Skye Bioscience, Inc.
(Updated on Jul 13, 2026)

Sell candidate since Jul 09, 2026 Loss -5.55%

The Skye Bioscience, Inc. stock price fell by -4.06% on the last day (Monday, 13th Jul 2026) from $0.690 to $0.662. It has now fallen 4 days in a row. During the last trading day the stock fluctuated 8.83% from a day low at $0.650 to a day high of $0.707. The price has fallen in 6 of the last 10 days and is down by -2.63% for this period. Volume has increased on the last day by 25 thousand shares but on falling prices. This may be an early warning and the risk will be increased slightly over the next couple of days. In total, 207 thousand shares were bought and sold for approximately $137.32 thousand.

The stock lies in the middle of a very wide and falling trend in the short term and further fall within the trend is signaled. Given the current short-term trend, the stock is expected to fall -19.71% during the next 3 months and, with a 90% probability hold a price between $0.477 and $0.704 at the end of this 3-month period.

SKYE Signals & Forecast

Furthermore, there is a buy signal from the 3 month Moving Average Convergence Divergence (MACD). Some negative signals were issued as well, and these may have some influence on the near short-term development. The Skye Bioscience, Inc. stock holds sell signals from both short and long-term Moving Averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average. On corrections up, there will be some resistance from the lines at $0.695 and $0.734. A break-up above any of these levels will issue buy signals. A sell signal was issued from a pivot top point on Thursday, May 28, 2026, and so far it has fallen -22.11%. Further fall is indicated until a new bottom pivot has been found. Skye Bioscience, Inc. gained volume on the last day, but on falling prices. In technical terms, this is called divergence and may be an early warning. In some cases, increasing volume on falling prices may be considered positive, but that is mainly in typical "sell-offs".

Support, Risk & Stop-loss for Skye Bioscience, Inc. stock

There is no support from accumulated volume below today's level and given the right condition the stock may perform very badly in the next couple of days.

This stock has average movements during the day and with good trading volume, the risk is considered to be medium. During the last day, the stock moved $0.0574 between high and low, or 8.83%. For the last week, the stock has had daily average volatility of 3.91%.

Our recommended stop-loss: We hold a negative evaluation for this stock. No stop-loss is set.

Trading Expectations (SKYE) For The Upcoming Trading Day Of Tuesday 14th

For the upcoming trading day on Tuesday, 14th we expect Skye Bioscience, Inc. to open at $0.673, and during the day (based on 14 day Average True Range), to move between $0.640 and $0.684, which gives a possible trading interval of +/-$0.0447 (+/-6.99%) up or down from last closing price. If Skye Bioscience, Inc. takes out the full calculated possible swing range there will be an estimated 6.99% move between the lowest and the highest trading price during the day.

With no support below and resistance from accumulated volume @ $0.714, some $0.0518 (7.82%) from the current price of $0.662, our system finds the risk reward not very attractive.

Is Skye Bioscience, Inc. stock A Buy?

Skye Bioscience, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

Current score: -4.534 Sell Candidate Unchanged

Predicted Fair Opening Price

Predicted fair opening price on July 14, 2026 - $0.673 ( 1.68%).

Want to trade but not sure how? Our step-by-step guide can help.
Skip the guide? Open account with our trusted broker* eToro
*Your capital is at risk

SKYE Performance

Trading levels for SKYE

StockInvest.us
Full Access. No Commitment. 7 Days Free!
Long & Short-Term Golden Star Lists
AI Stock Analysis*
Top 10 Candidates on Every List
Premium Lists
Ad-FREE Browsing
Advanced Stock Screener

Fibonacci Support & Resistance Levels

Level Price
R3 0.731 10.35%
R2 0.709 7.04%
R1 0.695 4.99%
Price 0.662
S1 0.651 -1.63%
S2 0.638 -3.68%
S3 0.616 -6.99%

Accumulated Volume Support & Resistance Levels

Level Price
R3 0.82 23.14%
R2 0.775 17.13%
R1 0.714 7.82%
Price 0.662
S1 0 -
S2 0 -
S3 0 -

FAQ

What is the symbol for Skye Bioscience, Inc. Stock and on which exchange is it traded?
The symbol for Skye Bioscience, Inc. is SKYE and it is traded on the PINK (Pink Sheets).

Should I buy or sell Skye Bioscience, Inc. Stock?
Skye Bioscience, Inc. holds several negative signals and is within a very wide and falling trend, so we believe it will still perform weakly in the next couple of days or weeks. We therefore hold a negative evaluation of this stock.

How to buy Skye Bioscience, Inc. Stock?
Skye Bioscience, Inc. Stock can be purchased through just about any brokerage firm, including online brokerage services.
Click here for our free guide on how to buy Skye Bioscience, Inc. Stock.

What's the current price of Skye Bioscience, Inc. Stock?
As of the end of day on the Jul 13, 2026, the price of an Skye Bioscience, Inc. (SKYE) share was $0.662.

What is the 52-week high and low for Skye Bioscience, Inc. Stock?
The 52-week high for Skye Bioscience, Inc. Stock is $4.99 and the 52-week low is $0.566.

What is the market capitalization of Skye Bioscience, Inc. Stock?
As of the Jul 13, 2026, the market capitalization of Skye Bioscience, Inc. is 23.265M.

When is the next earnings date for Skye Bioscience, Inc.?
The upcoming earnings date for Skye Bioscience, Inc. is Aug 06, 2026.
Click to get the best stock tips daily for free!
ABOUT SKYE BIOSCIENCE, INC.
Skye Bioscience
Skye Bioscience, Inc., a biopharmaceutical company, discovers, develops, and commercializes cannabinoid-based molecules for the treatment of infectious diseases. The company's lead product candidate is SBI-100, which is in Phase I trials for the treatment of glaucoma and ocular hypertension. It is also developing SBI-200 that is in preclinical trials to treat and manage various eye diseases, including uveitis, dry eye syndrome, macular degenerati...
GOLDEN STAR
Ticker Change Signal Date
SRPT
$17.02
10.58% Jun 29
NMRK
$15.02
0.466% Jun 24
X
XMAX
$8.34
2.40% Jun 24
NESR
$25.07
12.49% Jun 23
CAG
$13.43
6.70% Jun 23

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE